Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Second Affiliated Hospital of Nanchang University
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of mCRC;
Aged over 18 years;
Must be able to receive the further treatment in the hospital.
You may not be if
More than two types of malignancies;
Bacterial or virus infection within one month before diagnosis;
Taken anti-inflammatory drugs or other forms of chemotherapy before their diagnosis;
participants whose follow-up was interrupted three months ago without reaching any endpoint.
Clareo Health | Chronic Inflammation, Plasma Proteins Signature, Survival Outcomes and Clinical Response, in Patients Receiving Bevacizumab Combined With Oxaliplatin-based Chemotherapy (Bev/OX) or Bevacizumab Combined With Irinotecan-based Chemotherapy (Bev/IRI)
